102 related articles for article (PubMed ID: 7585590)
1. Lysine reduces renal accumulation of radioactivity associated with injection of the [177Lu]alpha-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate.
DePalatis LR; Frazier KA; Cheng RC; Kotite NJ
Cancer Res; 1995 Nov; 55(22):5288-95. PubMed ID: 7585590
[TBL] [Abstract][Full Text] [Related]
2. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.
Schlom J; Siler K; Milenic DE; Eggensperger D; Colcher D; Miller LS; Houchens D; Cheng R; Kaplan D; Goeckeler W
Cancer Res; 1991 Jun; 51(11):2889-96. PubMed ID: 1851665
[TBL] [Abstract][Full Text] [Related]
4. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
[TBL] [Abstract][Full Text] [Related]
5. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
Behr TM; Sharkey RM; Juweid ME; Blumenthal RD; Dunn RM; Griffiths GL; Bair HJ; Wolf FG; Becker WS; Goldenberg DM
Cancer Res; 1995 Sep; 55(17):3825-34. PubMed ID: 7641200
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
[TBL] [Abstract][Full Text] [Related]
7. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
[TBL] [Abstract][Full Text] [Related]
9. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
10. Strategies to reduce renal radioactivity levels of antibody fragments.
Arano Y
Q J Nucl Med; 1998 Dec; 42(4):262-70. PubMed ID: 9973841
[TBL] [Abstract][Full Text] [Related]
11. Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts.
Novak-Hofer I; Zimmermann K; Maecke HR; Amstutz HP; Carrel F; Schubiger PA
J Nucl Med; 1997 Apr; 38(4):536-44. PubMed ID: 9098198
[TBL] [Abstract][Full Text] [Related]
12. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules.
Schott ME; Milenic DE; Yokota T; Whitlow M; Wood JF; Fordyce WA; Cheng RC; Schlom J
Cancer Res; 1992 Nov; 52(22):6413-7. PubMed ID: 1423290
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435
[TBL] [Abstract][Full Text] [Related]
14. L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.
Kobayashi H; Yoo TM; Kim IS; Kim MK; Le N; Webber KO; Pastan I; Paik CH; Eckelman WC; Carrasquillo JA
Cancer Res; 1996 Aug; 56(16):3788-95. PubMed ID: 8706025
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
16. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.
Almqvist Y; Steffen AC; Tolmachev V; Divgi CR; Sundin A
Nucl Med Biol; 2006 Nov; 33(8):991-8. PubMed ID: 17127172
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
Mulligan T; Carrasquillo JA; Chung Y; Milenic DE; Schlom J; Feuerstein I; Paik C; Perentesis P; Reynolds J; Curt G
Clin Cancer Res; 1995 Dec; 1(12):1447-54. PubMed ID: 9815943
[TBL] [Abstract][Full Text] [Related]
19. Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues.
Miao Y; Fisher DR; Quinn TP
Nucl Med Biol; 2006 Aug; 33(6):723-33. PubMed ID: 16934691
[TBL] [Abstract][Full Text] [Related]
20. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
